The Two Lifecycles of Clinical Research

Every clinical study is two projects wearing one protocol. The first is the study everyone can see: participants recruited, visits conducted, treatments given, results published. The second is quieter: a body of data that must be defined before the first participant arrives and must outlive the last one by years. Most of what goes wrong in clinical research operations — and most of what technology is actually for — lives in the gap between the two.

This is the organizing framework of this publication: the study lifecycle and the data lifecycle run simultaneously, and data management and technology are what hold them together.

The study lifecycle

The study lifecycle is the sequence sponsors and sites organize around: Design → Build → Recruit & Enroll → Collect → Monitor & Clean → Code & Analyze → Close, Archive & Share. It is visible in Gantt charts, budgets, and enrollment dashboards. It has a natural constituency: investigators, coordinators, monitors, project managers.

The data lifecycle

The data lifecycle is what happens to the information itself: Define → Acquire → Validate → Transform → Protect → Use → Preserve. It is less visible and has a smaller constituency — data managers, informaticians, statisticians — but it is the lifecycle regulators, journals, and future researchers ultimately judge. A study that enrolled beautifully but cannot demonstrate where its numbers came from has failed at the second lifecycle, and the first cannot redeem it.

Walking the stages together

The framework earns its keep when you line the stages up and watch how each study-side decision lands on the data side.

Design ↔ Define

When a protocol specifies endpoints, visits, and assessments, it is — whether anyone says so — defining data: variables, timing, allowed values, and the metadata that gives numbers meaning. ICH E8(R1)'s quality-by-design principle is essentially this point made official: quality is designed in, not inspected in later ^[1]. Teams that treat protocol and study design and metadata and data dictionaries as one conversation avoid the classic failure of discovering at analysis time that a critical variable was never actually collected.

Build ↔ Define & Validate

Database build translates the protocol into eCRF design, visit schedules, and edit checks — the data lifecycle's definition work made executable, plus its validation logic written in advance. Every edit check is a prediction about how data will go wrong. Reusable form and study libraries are how organizations stop making the same predictions from scratch each time.

Recruit & Enroll ↔ Acquire

Enrollment is where data acquisition begins: eligibility determinations, consent records, baseline data. Errors made here — an ineligible participant, a consent version mismatch — propagate through everything downstream, which is why enrollment data deserves the strictest validation in the study.

Collect ↔ Acquire & Validate

During conduct, data arrives from everywhere at once: electronic data capture at sites, participant-reported outcomes, laboratory feeds, imaging and devices, EHR integration. The data lifecycle's demand is that acquisition and validation happen together — front-line edit checks catching problems at entry, while the data still has a person attached who remembers the visit.

Monitor & Clean ↔ Validate

Cleaning is validation industrialized: systematic checks, query management, source data review, and reconciliation across systems. ICH E6(R3)'s risk-based, proportionate approach to quality management ^[2] is a reminder the data lifecycle imposes discipline here too: the goal is not zero queries, it is confidence in the data that matters most.

Code & Analyze ↔ Transform & Use

Before analysis, raw data is transformed: adverse events coded with MedDRA, medications with WHODrug, datasets structured to CDISC standards where submissions require them, and delivered to statistical systems. This is the stage where definition debts come due — every ambiguity left in Define is now someone's derivation problem.

Close, Archive & Share ↔ Protect & Preserve

Database lock is the ceremony where the two lifecycles formally meet: the study declares the data final, and the data lifecycle takes custody. What follows — archiving and retention, de-identification for sharing, and increasingly, deposit under mandates like the NIH Data Management and Sharing Policy ^[4] — can last far longer than the study itself did.

One stage pair deliberately has no single home: Protect runs the full length of both lifecycles. Security controls, role-based permissions, and audit trails are not a phase; they are the condition under which every other phase is trustworthy.

What the two lifecycles produce together

When both lifecycles run well, they produce something neither can alone: a traceable chain from protocol to evidence.

Within the data management profession, the middle of this chain has its own well-established internal lifecycle — the one GCDMP practitioners will recognize ^[3]:

Why this matters for technology decisions

Most software evaluations are run by the study lifecycle's constituency, so demos naturally showcase study-side workflows: screens, visits, dashboards. The two-lifecycles framework is an argument for giving the data side equal scrutiny: how the system handles definition and metadata, mid-study changes without corrupting existing data, validation and query workflows at scale, export in formats statisticians and regulators can use, and audit trails and archives that will still be legible when the retention clock finally runs out. Our capabilities reference is organized around exactly these questions, and our guide From Protocol to Database Lock walks the chain end to end.

A study lifecycle without a data lifecycle produces activity without evidence. A data lifecycle without a study lifecycle produces pristine records of nothing. Clinical research needs both — and the work of connecting them is what this publication is about.